financial cost in the fourth quarter of 2018 were Baht 8.40 million decreased by Baht 4.96 million, or 37.16% from the previous year, due to the capital increase of the company in the second quarter. 5. For
million. The hospital and service revenues grew by 1.26% comprising 1.41% decrease of existing hospital operation and 25.56% increase of service revenues from the subsidiary (Asia Medical & Agricultural
period of 2018, increased by Baht 17.57 million or 22.7 percent as a result from increase in sale and the improvement of the inventory cost management as well as sales mix management in each product
same quarter of 2017, due to the capital increase of the company in the second quarter. 5. For the second quarter of 2018, the Company had net profit Baht 1.23 million decreased by Baht 52.54 million
increase of the company in the second quarter. 5. For the third quarter of 2018, the Company had net loss Baht 28.50 million decreased by Baht 0.85 million from the same quarter of 2017 mainly from better
”), the subsidiary, has indicated the growth by 12.35%. Costs and Expenses The Company reported the consolidated costs and expenses for Q3/2019 of Baht 365.61 million representing a slightly increase by
million which increase Baht 0.75 Million or 3.25% when compared to the same period of 2019. Resulting from increasing in the reserving of employment benefit obligation. 5. Financial Cost was Baht 2.22
million, a 9 .74% or Baht 37.72 million growing up from the same period of previous year. The hospital revenues grew by 10.04% mainly due to the increase in medical service income from Social Security
exported. Cost of Sales for Q2 / 2022 and Q2 / 2021 was 469.79 million baht and 453.66 million baht, respectively. It increased 16.13 million baht or 3.56% when compared with Q2 / 2021. The increase in cost
Bangkok, April 20, 2015 ? The SEC revealed that the Settlement Committee imposed a total fine of 6,254,024 baht on Sermkhun Kunawong, Chief Executive Officer and Director of CMO Plc. (CMO) for using